199 related articles for article (PubMed ID: 27475483)
1. The risk of second malignancies after
Fernandez Ots A; Browne L; Chin YS; Malouf D; Wong K; Bucci J
Brachytherapy; 2016; 15(6):752-759. PubMed ID: 27475483
[TBL] [Abstract][Full Text] [Related]
2. Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy.
Hamilton SN; Tyldesley S; Hamm J; Jiang WN; Keyes M; Pickles T; Lapointe V; Kahnamelli A; McKenzie M; Miller S; Morris WJ
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):934-41. PubMed ID: 25240272
[TBL] [Abstract][Full Text] [Related]
3. Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.
Musunuru H; Mason M; Murray L; Al-Qaisieh B; Bownes P; Smith J; Franks K; Carey B; Bottomley D; Henry AM
Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):210-5. PubMed ID: 24507938
[TBL] [Abstract][Full Text] [Related]
4. Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.
Hinnen KA; Schaapveld M; van Vulpen M; Battermann JJ; van der Poel H; van Oort IM; van Roermund JG; Monninkhof EM
J Clin Oncol; 2011 Dec; 29(34):4510-5. PubMed ID: 22025166
[TBL] [Abstract][Full Text] [Related]
5. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
6. Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?
Vigneault E; Martell K; Taussky D; Husain S; Delouya G; Mbodji K; Piotte J; Magnan S; Després P; Lavallée MC; Aubin S; Beaulieu L; Foster W; Martin AG
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1190-1194. PubMed ID: 29428250
[TBL] [Abstract][Full Text] [Related]
7. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
[TBL] [Abstract][Full Text] [Related]
8. Second malignancies after permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003.
Cosset JM; Belin L; Wakil G; Flam T; Thiounn N; Pierrat N; Pontvert D; Savignoni A; Chauveinc L
Cancer Radiother; 2017 May; 21(3):210-215. PubMed ID: 28499661
[TBL] [Abstract][Full Text] [Related]
9. Incidence of subsequent primary cancers and radiation-induced subsequent primary cancers after low dose-rate brachytherapy monotherapy for prostate cancer in long-term follow-up.
Vuolukka K; Auvinen P; Palmgren JE; Aaltomaa S; Kataja V
BMC Cancer; 2020 May; 20(1):453. PubMed ID: 32434560
[TBL] [Abstract][Full Text] [Related]
10. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
Farr DE; Thomas A; Khan SA; Schroeder MC
Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
[TBL] [Abstract][Full Text] [Related]
11. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
12. Commentary on "secondary cancers after intensity-modulated radiotherapy, brachytherapy, and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention." Zelefsky MJ, Pei X, Teslova T, Kuk D, Magsanoc JM, Kollmeier M, Cox B, Zhang Z. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.: BJU Int 2012;110:1696-701. doi: 10.1111/j.1464-410X.2012.11385.x. [Epub 2012 Aug 13].
Gottschalk A
Urol Oncol; 2014 Feb; 32(2):209. PubMed ID: 24445290
[TBL] [Abstract][Full Text] [Related]
13. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
Pawlish KS; Schottenfeld D; Severson R; Montie JE
Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
[TBL] [Abstract][Full Text] [Related]
14. Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients.
Muller J; Grosclaude P; Lapôtre-Ledoux B; Woronoff AS; Guizard AV; Bara S; Colonna M; Troussard X; Bouvier V; Trétarre B; Velten M; Jégu J
BJU Int; 2016 Jul; 118(1):53-9. PubMed ID: 26469096
[TBL] [Abstract][Full Text] [Related]
15. Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
Silva-Vieira M; Carrilho Vaz S; Esteves S; Ferreira TC; Limbert E; Salgado L; Leite V
Thyroid; 2017 Aug; 27(8):1068-1076. PubMed ID: 28614983
[TBL] [Abstract][Full Text] [Related]
16. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
[TBL] [Abstract][Full Text] [Related]
17. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
[TBL] [Abstract][Full Text] [Related]
18. Incidence of second primary cancers in North Portugal-a population-based study.
Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N
J Cancer Surviv; 2016 Feb; 10(1):142-52. PubMed ID: 26159159
[TBL] [Abstract][Full Text] [Related]
19. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis.
Wallis CJ; Mahar AL; Choo R; Herschorn S; Kodama RT; Shah PS; Danjoux C; Narod SA; Nam RK
BMJ; 2016 Mar; 352():i851. PubMed ID: 26936410
[TBL] [Abstract][Full Text] [Related]
20. Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patients.
Yorozu A; Kuroiwa N; Takahashi A; Toya K; Saito S; Nishiyama T; Yagi Y; Tanaka T; Shiraishi Y; Ohashi T
Brachytherapy; 2015; 14(2):111-7. PubMed ID: 25127123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
